Closed Solicitation · DEPT OF DEFENSE
AI Summary
The Defense Logistics Agency (DLA) is preparing to issue a presolicitation for a national requirements contract for Lamotrigine ER Tablets in various dosages (25MG, 50MG, 100MG, 200MG, 250MG, and 300MG) packaged in 30 count bottles. This acquisition will be unrestricted and fully competitive, structured as a firm-fixed price contract with a one-year base period and four additional one-year options. The contract aims to establish a national supply source for the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs through DLA
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Lamotrigine ER Tablets. Procurement details follow. Lamotrigine ER: 25MG, 50MG, 100MG, 200MG, 250MG and 300MG tablets in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Nancy Fernandez at (215) 737-4955 or Nancy.Fernandez@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is November of 2024. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
LAMOTRIGINE is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.